BioVaxys Technology Corp. (CSE:BIOV)
Canada · Delayed Price · Currency is CAD 0.2850
-0.0250 (-8.06%)
Oct 10, 2025, 9:41 AM EDT
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of CAD 9.10 million as of October 10, 2025. Its market cap has decreased by -38.60% in one year.
Market Cap
9.10M
Enterprise Value
9.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.29
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 9.10M, a decrease of -66.38%. That is a compound annual growth rate of -19.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 7.63M | -53.70% |
| Dec 31, 2024 | 16.48M | 127.10% |
| Dec 29, 2023 | 7.26M | -47.89% |
| Dec 30, 2022 | 13.92M | -26.37% |
| Dec 31, 2021 | 18.91M | 32.10% |
| Dec 31, 2020 | 14.32M | -47.09% |
| Oct 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.55B |
| Green Thumb Industries | 2.82B |
| Trulieve Cannabis | 2.34B |
| dentalcorp Holdings | 2.17B |
| Sienna Senior Living | 1.71B |
| WELL Health Technologies | 1.46B |
| Cronos Group | 1.45B |
| Extendicare | 1.23B |